MedPath

The effectiveness of group schematherapy combined with individual sessions in older adults with cluster B and/or C personality disorders

Phase 2
Recruiting
Conditions
personality disfunctioning
personality disorder
10034726
Registration Number
NL-OMON50945
Lead Sponsor
GGZ Breburg Groep (Rijen)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

1) age of 60 years or older;
2) willingness to participate in the study;
3) a primary diagnosis of a cluster B and/or C personality disorder according
to the categorical model of the DSM-5 (assessed with the Structured Clinical
Interview for DSM-5 Personality disorders (SCID-5-P) and according to the
alternative model of personality disorders (assessed with the Personality
Inventory of DSM-5 (PID-5) and the Severity Indices of Personality Problems
short form (SIPP-SF)).

Exclusion Criteria

1) a diagnosis of severe depression;
2) instable bipolar disorder; 3) acute psychotic disorder;
4) IQ under 80;
5) substance dependence that need detox;
6) autism spectrum disorder;
7) (moderate to severe) neurocognitive disorder (MOCA <25);
8) psychosocial circumstances that ask a lot of attention from the participant;
9) limited life expectancy due to severe somatic illness;

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>As a primary outcome measure, the credibility of the core beliefs (which are<br /><br>central to the PD) are assessed weekly. Participants will rate the credibility<br /><br>of their core beliefs on a Visual Analogue Scale (VAS) from 0 to 100 percent.<br /><br>The core beliefs are rated weekly during baseline phase and during treatment<br /><br>phase. The VAS will be scored at the start of each group session. During<br /><br>follow-up they will rated two times a month. The therapist will not be present<br /><br>when participants fill in this form to assure integrity. </p><br>
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath